Results of selective neck dissection in the primary management of head and neck squamous cell carcinoma

被引:52
|
作者
Schmitz, Sandra [1 ,5 ]
Machiels, Jean-Pascal [2 ,5 ]
Weynand, Birgit [3 ,5 ]
Gregoire, Vincent [4 ,5 ]
Hamoir, Marc [1 ,5 ]
机构
[1] Univ Catholique Louvain, Dept Head & Neck Surg, Head & Neck Oncol Program, St Luc Univ Hosp, B-1200 Brussels, Belgium
[2] Univ Catholique Louvain, Dept Oncol, Head & Neck Oncol Program, St Luc Univ Hosp, B-1200 Brussels, Belgium
[3] Univ Catholique Louvain, Dept Pathol, Head & Neck Oncol Program, St Luc Univ Hosp, B-1200 Brussels, Belgium
[4] Univ Catholique Louvain, Dept Radiat Oncol, Head & Neck Oncol Program, St Luc Univ Hosp, B-1200 Brussels, Belgium
[5] Univ Catholique Louvain, Ctr Canc, B-1200 Brussels, Belgium
关键词
Selective neck dissection; Lymph node metastasis; Head and neck cancer; Squamous cell carcinoma; UPPER AERODIGESTIVE TRACT; CERVICAL NODE METASTASES; NEGATIVE NECK; ORAL-CAVITY; PATTERNS; OROPHARYNX; TONGUE; RADIOTHERAPY; DELINEATION; RATIONALE;
D O I
10.1007/s00405-008-0767-9
中图分类号
R76 [耳鼻咽喉科学];
学科分类号
100213 ;
摘要
Selective neck dissection (SND) is known to be a valid procedure to stage the clinically N0 neck but its reliability to control metastatic neck disease remains controversial. This study analysed if selective neck dissection is a reliable procedure to prevent regional metastatic disease in head and neck squamous cell carcinoma (HNSCC). We retrospectively analysed the medical records of 163 previously untreated patients with squamous cell carcinoma of the oral cavity, oropharynx, larynx and hypopharynx treated initially in our departement from January 1990 to December 2002. All patients had unilateral or bilateral SND, in combination with surgical resection of the primary tumour. SND was performed in 281 necks. Finally, 146 patients who underwent 249 SND (39 I-III, I-IV, 210 II-IV, II-V) had adequate follow-up and were assessed for the regional control. The median follow-up was 37 months (1-180 months). The end points of the study were neck control following SND and overall survival. Twenty-five percent (30/119) of patients staged cN0 had lymph node (LN) metastasis. Overall, regional recurrence was observed in 2.8% of the necks (7/249): 1.6% (4/249) in dissected field and 1.2% (3/249) in undissected field. Seventy-eight percent (194/249) of the necks were staged pN0 with a subsequent failure rate of 1.5% (3/194); 16% (39/249) were staged pN1 and postoperative radiotherapy (PORT) was proposed in 21 of these patients. The failure rate with PORT was 9.5% and 5.5% without PORT. Six percent (16/249) of the necks were staged pN2b and all had PORT with one subsequent recurrence. Extracapsular spread (ECS) was reported in 16.5% of positive SND specimens (9/55); all by one were treated by PORT with a subsequent failure rate of 22% (2/9). At 3 years, overall survival for the whole population was 70% and statistically highly correlated with pN stage (p < 0.001). These results support the reliability of SND to stage the clinically N0 neck. SND is a definitive operation not only in pN0 but also in most pN1 and pN2b necks. PORT is not justified in pN1 neck without ECS. In pN2b necks, the low rate of recurrence supports adjuvant PORT. The presence of ECS, despite adjuvant PORT, remains associated with a higher risk of recurrence.
引用
收藏
页码:437 / 443
页数:7
相关论文
共 50 条
  • [1] Results of selective neck dissection in the primary management of head and neck squamous cell carcinoma
    Sandra Schmitz
    Jean-Pascal Machiels
    Birgit Weynand
    Vincent Gregoire
    Marc Hamoir
    European Archives of Oto-Rhino-Laryngology, 2009, 266 : 437 - 443
  • [2] Results of selective neck dissection in the management of head and neck squamous cell carcinoma
    Schmitz, S.
    Vandervorst, S.
    Beguin, C.
    Ledeghen, S.
    Desuter, G.
    Gregoire, V.
    Hamoir, M.
    RADIOTHERAPY AND ONCOLOGY, 2007, 82 : S75 - S75
  • [3] The evolving role of selective neck dissection for head and neck squamous cell carcinoma
    K. Thomas Robbins
    Alfio Ferlito
    Jatin P. Shah
    Marc Hamoir
    Robert P. Takes
    Primož Strojan
    Avi Khafif
    Carl E. Silver
    Alessandra Rinaldo
    Jesus E. Medina
    European Archives of Oto-Rhino-Laryngology, 2013, 270 : 1195 - 1202
  • [4] Head and neck squamous cell carcinoma:: Sentinel node or selective neck dissection
    Kovacs, Adorjan F.
    SURGICAL ONCOLOGY CLINICS OF NORTH AMERICA, 2007, 16 (01) : 81 - +
  • [5] The evolving role of selective neck dissection for head and neck squamous cell carcinoma
    Robbins, K. Thomas
    Ferlito, Alfio
    Shah, Jatin P.
    Hamoir, Marc
    Takes, Robert P.
    Strojan, Primoz
    Khafif, Avi
    Silver, Carl E.
    Rinaldo, Alessandra
    Medina, Jesus E.
    EUROPEAN ARCHIVES OF OTO-RHINO-LARYNGOLOGY, 2013, 270 (04) : 1195 - 1202
  • [6] Selective neck dissection for the treatment of neck metastasis from squamous cell carcinoma of the head and neck
    Chepeha, DB
    Hoff, PT
    Taylor, RJ
    Bradford, CR
    Teknos, TN
    Esclamado, RM
    LARYNGOSCOPE, 2002, 112 (03): : 434 - 438
  • [7] Selective Neck Dissection in Node-Positive Squamous Cell Carcinoma of the Head and Neck
    Givi, Babak
    Linkov, Gary
    Ganly, Ian
    Patel, Snehal G.
    Wong, Richard J.
    Singh, Bhuvanesh
    Boyle, Jay O.
    Shaha, Ashok R.
    Shah, Jatin P.
    Kraus, Dennis H.
    OTOLARYNGOLOGY-HEAD AND NECK SURGERY, 2012, 147 (04) : 707 - 715
  • [8] The Role of Neck Dissection in Squamous Cell Carcinoma of the Head and Neck
    Hamoir, Marc
    Schmitz, Sandra
    Gregoire, Vincent
    CURRENT TREATMENT OPTIONS IN ONCOLOGY, 2014, 15 (04) : 611 - 624
  • [9] The Role of Neck Dissection in Squamous Cell Carcinoma of the Head and Neck
    Marc Hamoir
    Sandra Schmitz
    Vincent Gregoire
    Current Treatment Options in Oncology, 2014, 15 : 611 - 624
  • [10] Selective neck dissection in the treatment of head and neck squamous cell carcinoma patients with a clinically positive neck
    Lopez, Fernando
    Fernandez-Vanes, Laura
    Garcia-Cabo, Patricia
    Grilli, Gianluigi
    Alvarez-Marcos, Cesar
    Luis Llorente, Jose
    Pablo Rodrigo, Juan
    ORAL ONCOLOGY, 2020, 102